BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37695745)

  • 1. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
    Spasevska I; Sharma A; Steen CB; Josefsson SE; Blaker YN; Kolstad A; Rustad EH; Meyer S; Isaksen K; Chellappa S; Kushekhar K; Beiske K; Førsund MS; Spetalen S; Holte H; Østenstad B; Brodtkorb M; Kimby E; Olweus J; Taskén K; Newman AM; Lorenz S; Smeland EB; Alizadeh AA; Huse K; Myklebust JH
    Blood Adv; 2023 Dec; 7(23):7216-7230. PubMed ID: 37695745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models.
    Stirm K; Leary P; Wüst D; Stark D; Joller N; Karakus U; Boyman O; Tzankov A; Müller A
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.
    Jeon SH; Kang M; Jeon M; Chung Y; Kim AR; Lee YJ; Kim ES; Nam H; Park J; Lee JY; Shin EC; Seo SI; Park SH
    Clin Cancer Res; 2023 May; 29(9):1794-1806. PubMed ID: 36716293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
    Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
    Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of selenium on regulatory T cell frequency and immune checkpoint receptor expression in patients with diffuse large B cell lymphoma (DLBCL).
    Dehghani M; Shokrgozar N; Ramzi M; Kalani M; Golmoghaddam H; Arandi N
    Cancer Immunol Immunother; 2021 Oct; 70(10):2961-2969. PubMed ID: 33721055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
    Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
    PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
    Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
    Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
    Voo KS; Foglietta M; Percivalle E; Chu F; Nattamai D; Harline M; Lee ST; Bover L; Lin HY; Baladandayuthapani V; Delgado D; Luong A; Davis RE; Kwak LW; Liu YJ; Neelapu SS
    Int J Cancer; 2014 Dec; 135(12):2834-46. PubMed ID: 24771328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.
    Keane C; Law SC; Gould C; Birch S; Sabdia MB; Merida de Long L; Thillaiyampalam G; Abro E; Tobin JW; Tan X; Xu-Monette ZY; Young KH; Gifford G; Gabreilli S; Stevenson WS; Gill A; Talaulikar D; Jain S; Hernandez A; Halliday SJ; Bird R; Cross D; Hertzberg M; Gandhi MK
    Blood Adv; 2020 Apr; 4(7):1367-1377. PubMed ID: 32267932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
    Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
    J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
    Pollari M; Pellinen T; Karjalainen-Lindsberg ML; Kellokumpu-Lehtinen PL; Leivonen SK; Leppä S
    Eur J Haematol; 2020 Dec; 105(6):712-721. PubMed ID: 32632935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
    Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
    Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and function of CD4
    Cha Z; Gu H; Zang Y; Wang Z; Li J; Huang W; Qin A; Zhu L; Tu X; Cheng N; Song H; Qian B
    Int Immunopharmacol; 2018 Aug; 61():132-139. PubMed ID: 29870918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
    Andor N; Simonds EF; Czerwinski DK; Chen J; Grimes SM; Wood-Bouwens C; Zheng GXY; Kubit MA; Greer S; Weiss WA; Levy R; Ji HP
    Blood; 2019 Mar; 133(10):1119-1129. PubMed ID: 30591526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.